Form D · Biotechnology

Photomedics Inc.

Cambridge, MA · CIK 0001833483

Offering snapshot reported Mar 3, 2023 · SEC filing

Reported sold
$1.16M
Offering amount: $2.32M
Investors reported
1
Form D · investor count
Minimum accepted
$1.16M
Reported outside-investor minimum
First sale
Nov 4, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.16M$2.32MNov 24, 2020: $2,319,000.00Nov 24, 2020Mar 3, 2023: $1,159,500.00Mar 3, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,319,000 → $1,159,500
  • Minimum accepted$2,319,000 → $1,159,500

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 3, 2023Amendment$1,159,500-$1,159,500vs Nov 24, 20201SEC filing
Nov 24, 2020Initial$2,319,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-381371
The total offering amount was up to $2,319,000.

Source: Form D, filed Mar 3, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Soto Mareskes Director, Executive
Njegos Solak Director
Nikolaos Soukos Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
245 First Street 17 Th Floor
Cambridge, MA, 02142